Heterogeneity of Checkpoint Inhibitor–Associated Pneumonitis: A Multicenter Study on Inflammatory Subtypes and Clinical Outcomes

Heterogeneity of Checkpoint Inhibitor–Associated Pneumonitis: A Multicenter Study on Inflammatory Subtypes and Clinical Outcomes

ABSTRACT Introduction Checkpoint inhibitor–associated pneumonitis (CIP) is a serious manifestation following tumor immunotherapy, typically mediated by T lymphocytes. However, the heterogeneity in blood inflammatory profiles and its implications on clinical characteristics and outcomes for CIP remai...

Full description

Saved in:
Bibliographic Details
Main Authors: Tingyue Luo, Tiantian Liu, Weisheng Chen, Wei Lei, Shuquan Wei, Yan Wang, Shudong Ma, Li Lin, Junjie Xi, Zeyu Fu, Jingze Guo, Qiang Xiao, Xiaodan Chang, Danhui Huang, Shifang Yang, Laiyu Liu, Shaoxi Cai, Hangming Dong
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Cancer Medicine
Subjects:
blood inflammation subtypes
checkpoint inhibitor–associated pneumonitis
clinical characteristics
heterogeneity
outcomes
Online Access:https://doi.org/10.1002/cam4.71041
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.71041

Similar Items